Targeting FGFR with BGJ398 in Breast Cancer: Effect on Tumor Growth and Metastasis

Abstract

FGFR inhibitors are promising tools that require further investigation to identify sensitive tumors. These studies suggest that targeting FGFR combined with other targeted therapies will be useful to impair breast cancer progression.